Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of the Aβ Peptides Salivary Dosage for Alzheimer's Disease Diagnosis

NCT02864303 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02864303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02864303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of the Aβ Peptides Salivary Dosage for Alzheimer's Disease Diagnosis
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
June 21, 2012
Completion date
October 11, 2018
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, mild cognitive impairment